Procter & Gamble
NASDAQ: PGKey stats
Price chart
About Procter & Gamble
Consumer products
Company profile
- IPO date
- Mar 22, 1950
- Website
- us.pg.com
Consumer Staples peers
How PG compares to other large companies in the same sector.
| Company | Price | Today | Market cap | P/E |
|---|---|---|---|---|
 WMT Walmart Inc. | $126.79 | -1.81% | $1.01T | 46.16 |
 COST Costco Wholesale | $998.49 | -3.25% | $442.97B | 51.82 |
 KO Coca-Cola Company | $77.49 | -0.88% | $333.18B | 25.42 |
 PEP PepsiCo Inc. | $157.08 | -0.26% | $214.65B | 26.05 |
 MDLZ Mondelez International | $59.02 | -0.12% | $75.63B | 30.86 |
Wall Street analyst ratings
DollarScout analysis
Editorial, not advice. See our methodology.
Bull case
Procter & Gamble’s competitive moat rests on its ownership of multiple leading household brands such as Tide, Pampers, and Gillette. These products have deeply penetrated households globally, ensuring consistent demand. With a beta of 0.4198, PG offers stability rare in the current market. The company's dominance in consumer staples assures investors of steady cash flows. Furthermore, PG's dividend yield of nearly 3% is an attractive feature for income-focused investors, mirroring its commitment to returning capital to shareholders. Analysts maintain a strong buy rating on PG, reflecting confidence in its ability to innovate within its sector and maintain its competitive edge.
Bear case
One key risk for PG is its relatively high P/E ratio of 20.5, which might be a signal of overvaluation, particularly if earnings growth fails to meet expectations. Competition in the consumer staples sector is fierce, with companies like Unilever and Colgate-Palmolive vying for market share. Any slip in product quality or consumer trust could undermine its brand strength. Additionally, while its beta suggests low volatility, this stability may also translate to slower growth compared to more aggressive market players. Lastly, currency fluctuations remain a risk due to PG's vast international operations, potentially impacting revenue numbers.
Who should buy PG
Long-term dividend investors willing to tolerate slow capital appreciation. PG is suitable for those seeking consistent income and preferring stability over high growth. Ideal for conservative portfolios aiming for steady, reliable returns with low risk.
Key risks
- PG's high P/E ratio might indicate overvaluation relative to earnings growth. - Intense competition from strong players like Unilever. - Currency fluctuations impacting international revenue. - Potential risks with maintaining brand trust if product quality or innovation lags.
Where to buy PG
Open an account with a broker we've reviewed and start trading Procter & Gamble today.
Want to practice first? Try the free Stock Trading Simulator with $100,000 virtual cash.
Recent PG news
Earlier this week, Procter & Gamble’s P&G PRO division launched Mr. Clean PRO, a professional-grade lineup of floor and surface cleaners aimed at commercial environments, including all-purpose, degreasing, all-surface, and deep-cleaning bleach products now available nationwide through distributors and retailers. This expansion of the Mr. Clean brand into business settings highlights P&G’s push to serve commercial cleaning needs with formulas tailored to the challenges professionals report,...
During the January-March 2026 period, Zefiro subsidiary P&G completed its first-ever project in Louisiana three weeks ahead of schedule, in addition to over 35% of wells in Wood 12F, its second-largest ever orphan well projectZefiro's revenue for FQ3 2026 is expected to be approximately USD $11.0 million1, representing an increase of over 50% compared to the same quarter in the prior yearBradford, Pennsylvania--(Newsfile Corp. - April 10, 2026) - ZEFIRO METHANE CORP. (Cboe Canada: ZEFI) (FSE:...
PG trades at premium P/E and P/S multiples versus peers despite soft demand and modest growth outlook, raising doubts about near-term upside.
Procter & Gamble expands its professional cleaning lineup with Mr. Clean PRO, targeting demand for high-performance solutions in commercial settings.
LOS ANGELES, CA / ACCESS Newswire / April 10, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-enhanced enzymes that transforms abundant feedstock into valuable nutraceuticals and novel medicines - announced that Chief Commercial ...
Top analysts changed outlook on top names. For complete view of all rating changes, see analyst ratings page. See others' views on stocks.
B of A Securities analyst Peter Galbo maintains Procter & Gamble (NYSE:PG) with a Buy and lowers the price target from $171 to $167.
Unilever (UL) pivots to Home & Personal Care after spin-offs, aiming for higher margins and growth. Read here for a detailed investment analysis.
Disclaimer: The information on this page is provided for informational and educational purposes only and should not be considered financial, investment, or trading advice. DollarScout does not recommend buying or selling any specific security. Stock data may be delayed. Past performance is not indicative of future results. Always do your own research and consult a licensed financial advisor before making investment decisions.